Skip to main content

EIT Health: Start-ups selected for the 2018 European Health Catapult

EIT Health InnoStars

The start-ups will proceed to the Semi-Finals of the competition

EIT Health has chosen the six best healthcare start-ups in the Innostars and RIS regions that will proceed to the Semi-Finals of the 2018 European Health Catapult for the categories of Biotech, MedTech and Digital Health. The European Health Catapult Competition (EHC) is a training and competition platform that awards the best-of-the-best business concepts from medtech, biotech and digital health across Europe.

EHC sources and accelerates 21 European start-ups in biotech, medtech and digital health that get high-quality training in business plan modelling, deal negotiation and pitch training, as well as a facilitated access to top level investors.

The official list of EIT Health Innostars healthcare companies selected to participate in the Semi-Finals of the 2018 European Health Catapult include:

Biotech

  • Kyme Nanoimaging Srl: Produces injectable medical products for Magnetic Resonance Imaging.The products aim to make anatomical details visible, ensuring better diagnosis, reducing side effects and widening the range of treatable patients. 
  • Synoesis Therapeutic LTD: SyNoesis Therapeutics is a start-up biotech with the vision to cure Parkinson's disease (PD) and other major brain diseases. They have patented a new therapy for Parkinson's Disease, that is now being further developed. 

Digital Health

  • DrOmnibus: creates modern digital tools that can be used in developmental and neurocognitive disorders, like Autism or Alzheimer. 
  • NeuroPsycad: NeuroPsycad uses artificial intelligence to identify disease ‘signatures’ of neurodegenerative illnesses in conventional brain scans.

Medtech

  • RI-TE Radiation Imaging Technologies, Lda: RI-TE is specialised in cost-effective PET scanners for education, training and preclinical research. 
  • Hydrustent: HydrUStent is a biodegradable, anti-bacterial and tailor-made stent which underlying technology has been protecting by a patent. HydrUStent reduces the risk of bacterial infection and cuts down half the number of surgical procedures, reducing the treatment cost by 60%.

The programme of the 2018 European Health Catapult will continue with two trainings, one organised by EIT Health, aiming to prepare teams for the EIT Health Summit in Lodz, this December.


Catch up with the latest news from the EIT Community in the Newsroom.

Subscribe to the EIT Newsletter to get the best of the EIT Community's news in your inbox once each month.

Do you use social media? Follow us and get updates in your news feed.